RCM Technologies, Inc.

Kevin Miller, Chief Financial Officer of Arsenal Technologies, and I am joined today by Brad Deasy, Arsenal's Executive Chairman. Our presentation in this call will contain forward-looking statements. The information contained in the forward-looking statements is based on our beliefs, estimates, assumptions, and information currently available to us, and these matters may materially change in the future. Many of these beliefs, estimates, and assumptions are subject to rapid changes. For more information on our four article statements and the risks, uncertainties, and other factors to which they are subject, please view the periodic reports on Forms 10-K, 10-Q, and 8-K that we file with the FEC, as well as our press releases that we issue from time to time. I will now turn the call over to Brad Yeezy, Executive Chairman, to provide an overview of our scenario's operating performance during the quarter.

And seven, good morning, everyone. Consistent with prior remarks, the internals of our business continue to strengthen at an increasing rate. We believe the company is well positioned based on the thoughtful investment strategy we have deployed and significant reductions in our share accounts should enhance the compounding of returns to benefit the shareholders. With stewardship as a foundational pillar to our zeitgeist, we believe we are positioned for continued outperformance. In fact, we have sharpened our focus on cultivating the next generation of leadership as we look through the end of the decade. Not only do we aim to maintain continuity in passing the baton, but assurance that the next generation is simply better than the ones before it. I strongly believe this is not only the capstone of one's career and a defining component of their legacy, but fundamental to the longevity and continued success of every organization. I am keenly focused on this being one of our hallmarks as a company and a strategic advantage when we look back years from now. With great enthusiasm about the present and well into the future, I will now provide an update on the progress of each of our business units. Erskine Healthcare is off to a strong start in 20.5. More importantly, as we look forward to next school year, the stage is set for continued momentum. Many of our largest school districts are on a robust road trajectory. Our presence in K-12, particularly in behavioral health, is stronger than ever as we stand in many existing schools and sign new school contracts for next school year. Also of note, our HIM division is starting to blossom, having cultivated a robust pipeline filled with high potential projects. With many prospective clients across all our groups and plans to expand our direct sales team, we are poised to seize these opportunities and drive significant growth. As we work towards a strong close of the 2024-2025 school year, planning is well underway for a strong start to the fall. Looking forward, the future of our health care setting is bright. In addition to onboarding new school districts, the hand-in-glove execution of our offshore team has been critical to extending our advantage, allowing us to ensure that children in schools receive the essential care they need Unlocking efficiencies in our organization has allowed us to double down on our investment in best practices and quality of care, further cementing our position as the greatest provider in K-12 nationwide. Success in our core K-12 market has opened other directed agencies, fueling investment in our sales team to galvanize growth for years to come. Transition to life sciences, data, and solutions. 2025 has brought significant opportunities for the IT industry in the form of accelerated technological advancements in the areas of artificial intelligence and machine learning. One year ago, only a few clients had an AI in their strategy. Today, we are seeing system deployments. We also see a significant expansion of manufacturing across our IT science and client base. Financial highlights in the quarter include the division posting a 40% gross profit, while maintaining a solid 23% NOI contribution. This is a tribute to strong managed service contracts, over-selling SG&A costs, and consistent delivery management of our projects. Respectively, we are in the early stages of building out our offshore resources base in this division. Maintaining momentum with this initiative will be key to helping us maintain and improve our market position for our key practices. while being highly competitive in our new BPO payroll offering. Our focus is revenue expansion and new client payment. So far in 2025, the division has opened six new clients, leveraging new service offerings ranging from asset management to design engineering. At the industry level, we are expecting to see shifts in services demand in the life sciences sector over the coming months. Facing increased lead times, organizations are seeking alternative sources of materials and talent. Using technology for quality improvement, direct cost reduction and headcount, automating manual or repetitive tasks is key for the remainder of 2025. In conclusion, our Q1 results demonstrate the strength of our core services. We have maintained a 90% plus renewal rate while not losing strength in our margins or bottom line. Turning to engineering. Starting with energy services. Since 2004, we have made significant strides with a strong focus on market opportunities and partnerships. Several substantive multi-year preferred partner agreements or comprehensive engineering services with increased scope are now in various stages of execution, progressing at an accelerating pace. We are capitalizing on the momentum we have built over the last several years as RCM quickly becomes a go-to partner in the industry. Opportunities for growth are abundant, driven by multi-decade themes including grid modernization, grid interconnect, and the proliferation of data centers. Any one of these variables represents strong secular demands. However, I believe that the confluence of We are quickly graduating from a hard-charging entrepreneurial organization with a drive to innovate to one that can effectively channel that innovative spirit to deliver the same distinguished outcome at scale. Our shared services functions not only facilitate knowledge transfer and best practices across business units, but further enhance operational efficiency and capacity to expand. We are seeing synergies across our core recruiting businesses, where we have demonstrated a clear competency to satisfy hard-to-sell requirements, then rapidly assimilating our new teammates into our can-do culture. Furthermore, we are in early stages of scaling up our near short and offshore capabilities, piggybacking on decades of goodwill built in niche geographies, affording us access to high-quality candidate pools. In summary, our outlook for the business has never been stronger. as we believe we are in the early stages of capitalizing on a foundation that has been productively laid over the last five years. In process and industrial, last quarter we announced the launch of the R3M Thermal Clinics office plant expansion program, primarily focused on the ethanol industry. The TK office is completing the first next project in early May. The project is an intensive process, and equipment engineers, effort followed by a six-week field coordination and management of installation crews, pipefitters, and related sub-suppliers that will result in a 20% SML plant capacity increase. There has been much interest from other SML plants in the project. We anticipate our next pipeline to increase significantly once this first project completes, the plant restart in early May. Other project activity includes the initiation of a Pilot campaigned at the TK Test Center as a follow-up to an engineering design purchase order related to lithium extraction and recovery from brine extracted from a USAID project. Equipment for this facility is scheduled for purchase in May 2025. As anticipated, the pilot test has yielded data valuable to scale-up on the project. An engineering order for a distillation solvent recovery has been received this week. This order was also the result of six weeks of lab testing to do this project. The equipment order is scheduled to immediately follow the eight-week engineering order. There has been a significant uptake in R2 activity at the TCA office. Improvements made to the digital presence of the organization is a strong contributing factor to the uptake. The team remains focused on the continuation of their emergence as a market leader in responsible and sustainable chemical process design. Since our activity in our aerospace group has increased materially, due to the awards on new and existing programs with historical and new clients in Q3 and Q4 2024, the aerospace and defense group has exceeded our business plan objectives for Q1 2025 by over 20% on revenue and almost 19% on EBITDA contribution. Headcount continues to increase for Q1 2025 by an additional 20%. with 50 new hires compared to Q4 2024. As projected, we have realized a significant increase in revenue, gross profit, and EBITDA in Q1 2025, with a weekly revenue run rate of about $1 million. a 47% increase in revenue compared to Q1 2024, a 45% increase in gross profit compared to Q1 2024, and an increase of 247% EBITDA contribution compared to 2024, primarily due to the overall increase in new business, ramp-up in our historic and ramp-up in our historical credit base, and after-market recovery contributing to and our new service and expertise in supply chain manufacturing and quality engineering with new clients will impact 2025 and beyond. We also continue to experience growth throughout new design programs and engineering with significant growth in the manufacturing environment on long-term supported products throughout the enterprise. Our recent wins with 2 in 15 customers on two large multi-year projects for years to come. The recruitment team continues to build trusted relationships throughout the client and candidate base, which has allowed this team to continue to exceed all hiring expectations throughout the quarter. In Q1 2025, we began integrating new tools and technologies to enhance our differentiating factor of intellect and speed to market amongst our competitors. We expect a new multi-year contract expertise in 2024 to help drive and expand our model-based expertise, software, systems, logistics, avionics, and aftermarket expertise throughout 2025 and 2026. We have also added three new clients in Q1 2025 with customers requiring our expertise in supply chain manufacturing and quality engineering realm and with manufacturing engineering support. In summary, we anticipate the anticipated growth with our existing and new aerospace investment clients in 2025 has begun to be realized. Most of our clients continue to need the support of a cost effective, high quality, flexible workforce in this current environment because of shorter term contracts with budgetary constraints. We look forward to continuing to build on our momentum throughout 2025. Before turning the call over to Kevin, It is worth noting that we have retired a little over 300,000 shares year to date, bringing combined repurchases over the last five years to just under half of shares outstanding, while maintaining a clean balance sheet with significant financial flexibility and resilient organic growth. Though the disconnect in our share price remains a head-scratcher, we will continue to act with alacrity when Mr. Marker offers to swap his dollar bills for our quarters. With an abundance of ambivalence and increasing enthusiasm about the future, I will return the call to Kevin to discuss the Q1 2025 financial results in more detail.

Thank you, Brad. Regarding our consolidated results, consolidated gross profit for the first quarter of 2025 was $22.0 million, which was 7.9% over Q1 2024, and yielded our highest gross profit over the past 12 quarters. Adjusted EBITDA for Q1 2025 was $7.8, million as compared to 6.2 million for Q1 2024, growth of 14.4%. Adjusted EPS for Q1 2025 was 63 cents as compared to 53 cents for Q1 2024, growth of 18.9%. As for our segment performance, the first quarter of 2025 in healthcare, gross profit for Q1 2025 was 12.2 million, compared to $11.1 million for Q1 2024, growing 10.2%. Growth margin for Q1 2025 was 28.2%, as compared to 29.0% for Q1 2024. School revenue for Q1 2025 was $37.3 million, compared to $31.9 million for Q1 2024, growth of 16.7%. Non-school revenue for Q1 2025 was $6.0 million compared to $6.3 million for Q1 2024. However, if we remove a large long-term care group where we deliver and reduce services, revenue would be $5.5 million versus $5.1 million. In engineering, gross profits for Q1 2025 was $6.2 million compared to $5.5 million for Q1 2024. growing 12.4% and our best engineering gross profit quarter in our history. Gross margin for Q1 2025 was 19.2% compared to 23.4% for Q1 2024. Gross margin in the first quarter of 2025 was lower than normal, primarily for two reasons. We had significant passive construction revenue from our EPC contracts and our energy services group. If we normalize gross margin for construction labor tax-revenue only, gross margin was approximately 22.7% versus 25.8%. We also experienced significant growth from our average base fruit, which had lower gross margin, but a very reasonable operating margin. As a reminder, our engineering gross margin can be volatile. but we generally expect normalized gross margins between 22% and 26%. In IT, life sciences, and data solutions, gross profits for Q1 2025 was $3.6 million compared to $3.8 million for Q1 2024, declining by 5.3%. Gross margin for Q1 2025 was 39.7% compared to 37.0% for Q1 2024. Regarding our balance sheet, We made good progress on our cash receivable DSOs in Q1 2025 at about 74 days compared to about 92 days for Q4 2024. Our cash receivable reduction helped us generate $16.7 million in cash flow from operations. We also reduced our net debt by $12.0 million to $18.2 million for Q1 2025 as compared to $30.2 million for Q4 2024. We are optimistic we can keep our DSOs under 80 days going forward. We expect to continue to deliver at least low double-digit growth in adjusted EBITDA throughout fiscal 2025. Also, while we don't necessarily expect a fourth quarter jump in adjusted EBITDA that we saw in fiscal 2023, we believe Q4 2025 will produce our highest adjusted EBITDA quarter for the year. This concludes our prepared remarks. At this time, we will open the call for questions.

And with that, ladies and gentlemen, you may press star 1 on your telephone keypad for questions. That is star 1 on your telephone keypad to join the question queue. All right. First up, we have Liam Burke. Liam, your line is now open.

Thank you. Good morning, Brad. Good morning, Kevin.

Good morning.

Brad, I know you I know you're primarily services, but there's a lot of political policy uncertainty out there. Is any of that moving into your business or any of it a concern to you in any of your business lines?

No, Liam, thanks for the question. Fortunately, Kevin and I have yet to come across smooth for Holly. generally speaking macroeconomic environment we try and think about setting the business up as you know to the extent that it does impact us we can have a year around it but generally you know we have ourselves a set of themes for which we can take advantage of so you know I'll tell you you know it's my job every night before I go to bed to have five things on my mind the macroeconomic environment has never been one of them so haven't seen an issue so far

Great. That's good to hear. And, Kevin, you talked about gross margins on engineering and walked through the delta. Looking at health care, it looks like you're growing your more profitable business and the legacy business is being worn off. You had a slightly lower year-over-year gross margin. Is that just working through the old legacy business?

Well, it's more of a just sort of, you know, quarterly noise that you're going to see. You know, there is a little bit of a mixed shift there in terms of, you know, some of our nursing contracts that are maybe a little bit lower gross margin, you know, than some other contracts, you know, behavioral health, for instance. But, you know, it's kind of the normal noise that you would expect to see from quarter to quarter. Nothing really specific other than maybe a little bit of a bump in some – you know, new nursing contracts or existing nursing contracts either that have a little bit lower gross margin than the behavioral health. But, you know, there's no, like, you know, trend there where we expect any significant erosion in margin as we're sitting here today. And I would expect that, you know, Q2 will be a little bit better than Q1.

Okay. So we'll figure maybe more in operating range similar to your other businesses.

Exactly. Exactly. And usually, you know, we gave some guidance on general ranges on our last call, and health care certainly fell within that range.

Super. Thank you, Brad. Thank you, Kevin.

All right. Once again, ladies and gentlemen, that is star 1 to join the question queue. Star 1 to join the question queue. And at this time, I'm not seeing any further questions in queue. Just as a reminder, that's star 1 on your telephone keypad. All right, gentlemen. I'm still seeing no questions, aren't you?

All right. Thank you, everyone, for attending Arkham's first quarter conference call. We look forward to our next update in August.

And with that, ladies and gentlemen, this does conclude your call. You may now disconnect your lines, and thank you again for joining us today.